XF
ABBV icon

XML Financial’s AbbVie ABBV Stock Holding History

XML Financial’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.52M Sell
9,996
-190
-2% -$40.9K 0.18% 112
2026
Q1 		$2.22M Buy
10,186
+7
+0.1% +$1.55K 0.18% 114
2025
Q4 		$2.33M Sell
10,179
-813
-7% -$185K 0.19% 108
2025
Q3 		$2.55M Sell
10,992
-217
-2% -$44.2K 0.21% 100
2025
Q2 		$2.08M Sell
11,209
-461
-4% -$85.7K 0.18% 116
2025
Q1 		$2.45M Sell
11,670
-2,528
-18% -$491K 0.23% 94
2024
Q4 		$2.52M Buy
14,198
+4
+0% +$735 0.23% 98
2024
Q3 		$2.8M Sell
14,194
-165
-1% -$30.8K 0.26% 95
2024
Q2 		$2.46M Sell
14,359
-317
-2% -$52.5K 0.25% 97
2024
Q1 		$2.67M Sell
14,676
-2,211
-13% -$381K 0.27% 93
2023
Q4 		$2.62M Buy
16,887
+204
+1% +$29.7K 0.28% 97
2023
Q3 		$2.49M Sell
16,683
-263
-2% -$38.6K 0.3% 90
2023
Q2 		$2.28M Sell
16,946
-272
-2% -$39.9K 0.26% 96
2023
Q1 		$2.74M Sell
17,218
-33,427
-66% -$5.11M 0.33% 85
2022
Q4 		$8.18M Buy
50,645
+169
+0.3% +$25.9K 1.03% 24
2022
Q3 		$6.77M Buy
50,476
+42,248
+513% +$6.06M 0.94% 36
2022
Q2 		$1.26M Sell
8,228
-42,109
-84% -$6.43M 0.28% 71
2022
Q1 		$8.16M Sell
50,337
-118
-0.2% -$17.1K 0.97% 29
2021
Q4 		$6.83M Buy
50,455
+13
+0% +$1.54K 0.82% 35
2021
Q3 		$5.44M Buy
50,442
+43,492
+626% +$4.97M 0.73% 41
2021
Q2 		$783K Sell
6,950
-47
-0.7% -$5.29K 0.17% 106
2021
Q1 		$757K Sell
6,997
-904
-11% -$96.7K 0.18% 104
2020
Q4 		$847K Buy
7,901
+1,118
+16% +$107K 0.22% 93
2020
Q3 		$594K Buy
6,783
+1,892
+39% +$178K 0.19% 99
2020
Q2 		$480K Buy
4,891
+866
+22% +$76.2K 0.17% 104
2020
Q1 		$307K Sell
4,025
-693
-15% -$59K 0.13% 118
2019
Q4 		$418K Buy
+4,718
New +$392K 0.15% 113

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

XML Financial's ABBV Position: Q2 2026 in Review

XML Financial reduced its AbbVie (ABBV) stake by 1.9% in Q2 2026, selling an estimated $40.9K and leaving 9,996 shares worth $2.52M. The position accounts for 0.18% of the portfolio, ranked #112.

XML Financial first reported a position in ABBV in Q4 2019 and has held it in 27 quarters since. The position peaked at $8.18M in Q4 2022. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • XML Financial held 9,996 shares of AbbVie worth $2.52M as of Q2 2026.
  • XML Financial sold 190 AbbVie shares in Q2 2026, an estimated $40.9K.
  • AbbVie made up 0.18% of XML Financial's portfolio in Q2 2026, its #112 holding.
  • XML Financial first reported a position in AbbVie in Q4 2019 and has held it in 27 quarters since.
  • XML Financial's AbbVie position peaked at $8.18M in Q4 2022.
  • 4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on XML Financial's 13F filing for Q2 2026, filed 24 Jul 2026.